Is Merus NV halal to invest in?

According to Musaffa's Shariah screening methodology, Merus NV (MRUS) is currently classified as NOT HALAL as of November 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Merus NV a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Merus NV using these criteria to determine its compliance status.

Can Muslims buy shares of Merus NV?

Muslim investors may consider investing in Merus NV if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Merus NV classified as NOT HALAL?

Musaffa determines the Shariah status of Merus NV by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Merus NV updated?

The Shariah compliance status of Merus NV may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Merus NV become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Merus NV?

You can check the latest Shariah compliance status of Merus NV on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

MRUS Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: November 06, 2025

Report Source: 2025 3rd Quarter Report

Analyst's Ratings for Merus NV (MRUS)

Based on 24 analysts giving stock ratings to Merus NV in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Merus NV. Stock Analysis MRUS

United States Health Care Mid Cap Report: Q3, 2025

Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. The company is headquartered in Utrecht, Utrecht and currently employs 260 full-time employees. The company went IPO on 2016-05-19. The product programs in the Merus pipeline are based on the Multiclonics format. Its products are designed to bind to multiple targets, and are manufactured with features for anti-cancer effects against the complex mechanisms that drive cancer. Company's products engage cancer antigens and harness the power of the immune system to kill tumor cells by utilizing technology platform. One of the drug zenocutuzumab (Zeno), a Biclonics antibody, concentrates on helping patients with lung, pancreatic and other types of solid tumors. The firm operates in the Netherlands and United States.

Key Statistics of Merus NV (MRUS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$87.14$96.86

Today's Open

$96.86

Volume

2.73M

P/E Ratio (TTM)

52 Week Range

$33.19$97.14

Market Cap

6.83B

Avg. Volume

1.21M

Dividend Yield

Financial Metrics & Statements of Merus NV (MRUS)

FAQ's for Merus NV (MRUS)

According to Musaffa’s Shariah screening methodology, Merus NV (MRUS) is currently classified as NOT HALAL as of November 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.